Ebola — DR Congo
Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), have discovered a new set of broadly neutralizing monoclonal antibodies (mAbs) in the blood of Ebola survivors, which proved protective against disease caused by _Zaire_, _Bundibugyo_, and _Sudan_ ebolaviruses. The findings were published today in the journal Immunity.
In the study, the researchers analyzed plasma from 17 Ebola survivors and found that 2 survivors produced antibodies that bound to an
…
